reglab/statecodes huggingface dataset:
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0125 - Drug: Storage

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A RDSP must
			 maintain proper storage of all drugs. This includes, but is not limited to the
			 following:
(a) All drugs must be stored
			 according to manufacturer's published or USP guidelines.
(b) All drugs must be stored in appropriate
			 conditions of temperature, light, humidity, sanitation, ventilation, and
			 space.
(c) Appropriate storage
			 conditions must be provided for, including during transfers between facilities
			 and to patients.
(d) A RDSP must
			 quarantine drugs which are outdated, adulterated, misbranded or suspect. Cold
			 Storage and Monitoring.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0130 - Drug: Loss

Current through Register Vol. 63, No. 7, July 1, 2024
A RDSP and its RDSP Affiliated Pharmacy must:
(1) Ensure that disasters, accidents and
			 emergencies which may affect the strength, purity, or labeling of drugs or
			 devices are reported to the board immediately.
(2) Ensure that confirmed significant drug
			 loss or any loss related to suspected drug theft of a controlled substance is
			 reported to the board within one business day.
(3) Ensure that a Report of Theft or Loss of
			 Controlled Substances (DEA Form 106) or Report of Theft or Loss of Listed
			 Chemicals (DEA Form 107) is sent to the Drug Enforcement Administration, a copy
			 is sent to the board at the same time.
Statutory/Other Authority: ORS
				  475.035, ORS
				  689.205 & ORS
				  689.315
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0145 - Outlet: Closure- Temporary, Permanent and Emergency

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 Temporary Closing. Unless subject to an exemption in OAR
			 855-139-0145(3),
			 when a RDSP is temporarily closed to the public the RDSP must:
(a) Post notification of closure on each RDSP
			 entrance as soon as the need to deviate from the posted hours is known by the
			 RDSP, but no later than 2 hours after the temporary closure begins. The posting
			 must include:
(A) Estimated period of time the
			 RDSP will be closed; and
(B)
			 Options for prescription pick-up (e.g. another local pharmacy, contact
			 prescriber for new prescription, reverse processed prescriptions).
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0150 - Outlet: Sanitation

Current through Register Vol. 63, No. 7, July 1, 2024
A RDSP and its RDSP Affiliated Pharmacy must:
(1) Ensure the RDSP is kept clean.
(2) Ensure the Certified Oregon Pharmacy
			 Technician or Pharmacy Technician working in the RDSP practices appropriate
			 infection control.
Statutory/Other Authority: ORS
				  689.305 & 2022 HB
				  4034
Statutes/Other Implemented: ORS
				  689.305 & 2022 HB
				  4034
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0155 - Outlet: Minimum Equipment Requirements

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Each Oregon Retail Drug Outlet RDSP must
			 have the following:
(a) Appropriate and
			 current pharmaceutical references (e.g., pharmacology, injectables, and
			 veterinary drugs) services offered by the outlet;
(b) Appropriate and current Oregon Revised
			 Statutes, Oregon Administrative Rules, United States Code, Code of Federal
			 Regulations, standards adopted by reference (e.g., USP) based on services
			 offered by the outlet and a minimum of three years of the Board of Pharmacy
			 quarterly newsletters;
(c) Access
			 to appropriate electronic reporting databases (e.g., PDMP, NPLEx, OHA
			 ALERT-IIS) based on the services offered by the outlet;
(d) Appropriate equipment to maintain the
			 proper storage of drugs;
(e)
			 Appropriate equipment and supplies as required by Oregon Revised Statutes,
			 Oregon Administrative Rules, United States Code, Code of Federal Regulations,
			 and standards adopted by reference (e.g., USP) based on services offered by the
			 outlet;
(f) A sink with running hot
			 and cold water;
(g) Signage in a
			 location easily seen by the public where prescriptions are dispensed or
			 administered:
(A) Stating "This pharmacy may
			 be able to substitute a less expensive drug which is therapeutically equivalent
			 to the one prescribed by your doctor unless you do not approve." The printing
			 on this sign must be in block letters not less than one inch in
			 height.
(B) Providing notification
			 in each of the languages required in OAR
			 855-139-0410 of the right to
			 free, competent oral interpretation and translation services, including
			 translated prescription labels, for patients who are of limited English
			 proficiency, in compliance with federal and state regulations if the pharmacy
			 dispenses prescriptions for a patient's self-administration;
(C) Providing written notice in a conspicuous
			 manner that short-acting opioid antagonists (e.g., naloxone, nalmefene) and the
			 necessary medical supplies to administer short-acting opioid antagonists are
			 available at the pharmacy if short-acting opioid antagonist services are
			 provided by the pharmacy;
(D)
			 Stating "This location is a Remote Dispensing Site Pharmacy, supervised by an
			 Oregon licensed Pharmacist from (insert name of RDSP Affiliated Pharmacy,
			 address, and telephone number)." The printing on the sign must be in block
			 letters not less than one inch in height; and
(E) Providing notification of accurate hours
			 of operation at each pharmacy entrance; and
(h) Accurate hours of operation on each
			 telephone greeting and pharmacy-operated internet (e.g. website, social media,
			 mobile applications).
(i)
			 Additional equipment and supplies that are determined as necessary by the
			 Pharmacy or Pharmacist-in-Charge.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0200 - Outlet: General Requirements

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 A RDSP Affiliated Pharmacy may not be affiliated with more than two Remote
			 Dispensing Site Pharmacies.
(2) A
			 RDSP Affiliated Pharmacy must be less than 120 miles apart via the shortest
			 surface street route from the RDSP.
(3) A RDSP and its RDSP Affiliated Pharmacy
			 must:
(a) Have the same owner; or
(b) Have a written contract that specifies:
(A) The services to be provided by each
			 licensee and registrant;
(B) The
			 responsibilities of each licensee and registrant; and
(C) The accountabilities of each licensee and
			 registrant;
(c) Ensure
			 each prescription is dispensed in compliance with OAR 855-115, OAR 855-125 and
			 OAR 855-139;
(d) Comply with all
			 applicable federal and state laws and rules;
(e) Designate in writing the Oregon licensed
			 Pharmacists and Certified Oregon Pharmacy Technicians authorized to access the
			 RDSP and operate the telepharmacy system;
(f) Train the Oregon licensed Pharmacists and
			 Certified Oregon Pharmacy Technicians in the operation of the telepharmacy
			 system and RDSP;
(g) Develop,
			 implement and enforce a continuous quality improvement program for dispensing
			 services from a RDSP designed to objectively and systematically:
(A) Monitor, evaluate, document the quality
			 and appropriateness of patient care;
(B) Improve patient care; and
(C) Identify, resolve and establish the root
			 cause of dispensing and DUR errors and prevent their reoccurrence;
(h) Provide a telephone number
			 that a patient, patient's agent or prescriber may use to contact the Oregon
			 licensed Pharmacist from the RDSP Affiliated Pharmacy; and
(i) Develop, implement and enforce a process
			 for an in person physical inspection of the RDSP by an Oregon licensed
			 Pharmacist at least once every 28 days or more frequently as deemed necessary
			 by the Oregon licensed Pharmacist-in-charge of the RDSP Affiliated Pharmacy.
			 The inspection must utilize the RDSP self-inspection form, be documented, and
			 records retained.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0205 - Outlet: Technology

Current through Register Vol. 63, No. 7, July 1, 2024
A RDSP and its RDSP Affiliated Pharmacy must:
(1) Utilize a shared telepharmacy system and
			 have appropriate technology or interface to allow access to information
			 required to process and fill a prescription drug order;
(2) Use still image capture or store and
			 forward for verification of prescriptions with a camera that is of sufficient
			 quality and resolution so that the Oregon licensed Pharmacist from the RDSP
			 Affiliated Pharmacy can visually identify each:
(a) Source container including manufacturer,
			 name, strength, lot, and expiration;
(b) Source ingredient including the imprint
			 and physical characteristics if compounding;
(c) Dispensed product including the imprint
			 and physical characteristics;
(d)
			 Completed prescription container including the label; and
(e) Ancillary document provided to patient at
			 the time of dispensing.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0210 - Outlet: Supervision

Current through Register Vol. 63, No. 7, July 1, 2024
A RDSP and its RDSP Affiliated Pharmacy must:
(1) Ensure prescription drugs are only
			 dispensed at the RDSP if an Oregon licensed Pharmacist is supervising the
			 Certified Oregon Pharmacy Technician or Pharmacy Technician, and the
			 surveillance system is fully operational;
(2) Ensure an Oregon licensed Pharmacist
			 supervises, directs and controls each Certified Oregon Pharmacy Technician or
			 Pharmacy Technician at the RDSP using an audiovisual communication system. All
			 patient interactions must be recorded, reviewed and stored;
(3) The Oregon licensed Pharmacist who is
			 supervising the Certified Oregon Pharmacy Technician or Pharmacy Technician at
			 a RDSP must:
(a) Using reasonable professional
			 judgment, determine the percentage of patient interactions for each licensee
			 that must be reviewed to ensure public health and safety with a minimum of 10%
			 of patient interactions observed or reviewed;
(b) Review patient interactions within 48
			 hours of the patient interaction to ensure that each licensee is acting within
			 the authority permitted under their license and patients are connected with a
			 Pharmacist upon request;
(c)
			 Document the following within 24 hours of the review in (3)(b):
(A) Number of each licensee's patient
			 interactions;
(B) Number of each
			 licensee's patient interactions Pharmacist is reviewing;
(C) Date and time of licensee patient
			 interaction Pharmacist is reviewing;
(D) Date and time of Pharmacist review of
			 licensee's patient interaction; and
(E) Pharmacist notes of each interaction
			 reviewed; and
(d) Report
			 any violation of OAR 855 to the RDSP Affiliated Pharmacy within 24 hours of
			 discovery and to the board within 10 days.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0215 - Outlet: Pharmacist Utilization

Current through Register Vol. 63, No. 7, July 1, 2024
A RDSP and its RDSP Affiliated Pharmacy must:
(1) Utilize an Oregon licensed Pharmacist
			 from the RDSP Affiliated Pharmacy to perform the professional tasks of
			 interpretation, evaluation, DUR, verification and counseling before the
			 prescription is dispensed; and
(2)
			 Utilize an Oregon licensed Pharmacist and an audiovisual communication system
			 to provide counseling or accept the refusal of counseling from the patient or
			 the patient's agent for each prescription being dispensed when counseling is
			 required under OAR 855-115-0145 and when requested
			 and document the interaction.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0220 - Outlet: Non-Prescription Drugs

Current through Register Vol. 63, No. 7, July 1, 2024
If non-prescription drugs are offered for sale at the RDSP, the
				RDSP and its RDSP Affiliated Pharmacy must:
(1) Ensure that the Certified Oregon Pharmacy
			 Technician or Pharmacy Technician does not provide advice, information that
			 requires judgment, or recommendations involving non-prescription drugs;
			 and
(2) Ensure that an
			 Oregon-licensed Pharmacist is immediately available to provide counseling or
			 recommendations involving non-prescription drugs.
Statutory/Other Authority: ORS
				  689.205 & 2022 HB
				  4034
Statutes/Other Implemented: ORS
				  689.155 & 2022 HB
				  4034
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0225 - Outlet: Controlled Substances

Current through Register Vol. 63, No. 7, July 1, 2024
If controlled substances are at the RDSP, the RDSP and its RDSP
				Affiliated Pharmacy must:
(1) Comply
			 with controlled substance regulations;
(2) Store all controlled substances in a
			 secure locked cabinet;
(3) Maintain
			 an accurate controlled substance perpetual inventory; and
(4) Ensure an Oregon licensed Pharmacist
			 conducts a controlled substance inventory at least once every 28 days and
			 reconciles all discrepancies at the time of in person physical
			 inspection.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0230 - Outlet: Non-Sterile Compounding

Current through Register Vol. 63, No. 7, July 1, 2024
If non-sterile preparations are compounded at the RDSP, the
				RDSP and its RDSP Affiliated Pharmacy must:
(1) Adhere to the requirements of OAR
			 855-045;
(2) Ensure an Oregon
			 licensed Pharmacist:
(a) Supervises via an
			 audiovisual communication system all steps of the compounding; and
(b) Documents and visually verifies each item
			 required in OAR 855-139-0205.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0300 - Prescription: General Requirements

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 Prescriptions, prescription refills, and drug orders must be correctly
			 dispensed in accordance with the prescribing practitioner's authorization. When
			 a prescription is transmitted orally, it must be transmitted to the Oregon
			 licensed Pharmacist from the RDSP Affiliated Pharmacy and both the receiving
			 pharmacist's name or initials and the name of the person transmitting must be
			 noted on the prescription.
(2) Each
			 RDSP must document the following information for each prescription:
(a) The name and date of birth of the patient
			 for whom the drug is prescribed, unless for an animal.
(b) If for an animal, the name of the
			 patient, name the owner and the species of the animal.
(c) The full name, address, and contact phone
			 number of the practitioner. If for a controlled substance, the Drug Enforcement
			 Administration registration number of the practitioner and other number as
			 authorized under rules adopted by reference under rule OAR
			 855-080-0085;
(d) The name, strength, dosage forms of the
			 substance, quantity prescribed and, if different from the quantity prescribed,
			 the quantity dispensed;
(e) The
			 directions for use, if given by the practitioner; and
(f) The date of filling, and the total number
			 of refills authorized by the prescribing practitioner.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0305 - Prescription: Tamper-resistant

Current through Register Vol. 63, No. 7, July 1, 2024
When the use of a tamper-resistant prescription is required by
				any federal or state law or rule, the term "tamper-resistant" has the meaning
				as defined in OAR 855-006-0005.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0310 - Prescription: Verification of Authenticity

Current through Register Vol. 63, No. 7, July 1, 2024
Alteration of a written prescription, other than by an Oregon
				licensed Pharmacist's or practitioner's authorization, in any manner
				constitutes an invalid order unless verified with the prescriber.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.151 & ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0315 - Prescription: Refills

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Where refill
			 authority is given other than by the original prescription, documentation that
			 such refill authorization was given, the date of authorization, and name of the
			 authorizing prescriber or the prescriber's agent must be recorded. This
			 documentation must be readily retrievable. Prescriptions for controlled
			 substances in Schedules III, IV and V are limited to five refills or six months
			 from date of issue, whichever comes first.
(2) If the practitioner is not available and
			 in the reasonable professional judgment of the Oregon licensed Pharmacist an
			 emergency need for the refill of a prescription drug has been demonstrated, the
			 Oregon licensed Pharmacist may authorize the Certified Oregon Pharmacy
			 Technician or Pharmacy Technician to prepare for Pharmacist verification a
			 sufficient quantity of the drug consistent with the dosage regimen, provided it
			 is not a controlled substance, to last until a practitioner can be contacted
			 for authorization, but not to exceed a 72-hour supply. The practitioner must be
			 promptly notified of the emergency refill.
(3) Each refilling of a prescription must be
			 accurately documented, readily retrievable, and uniformly maintained for three
			 years. This record must include;
(a) The
			 identity of the Certified Oregon Pharmacy Technician or Pharmacy Technician and
			 responsible Oregon licensed Pharmacist;
(b) Name of the patient;
(c) Name of the medication;
(d) Date of refill; and
(e) Quantity dispensed.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0320 - Prescription: Expiration

Current through Register Vol. 63, No. 7, July 1, 2024
This section of rule addresses the expiration date of the
				prescription and not the expiration date of the drug.
(1) After one year from date of issue, a
			 prescription for a non-controlled substance becomes invalid and must be
			 re-authorized by the prescriber.
(2) When used alone as a prescription refill
			 designation the abbreviation, "PRN" for a non-controlled substance means that
			 the medication can be refilled in proper context for a period of one year.
(a) When this abbreviation is used alone as a
			 means to authorize refills for a controlled substance, the medication can be
			 refilled in proper context for a period of six months or five refills,
			 whichever comes first.
(b) When
			 this abbreviation is used in conjunction with a definite time period, or a
			 specific number of refills, the non-controlled medication can be refilled in
			 proper context for a period not to exceed one year.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0325 - Prescription: Transfers

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 Prescriptions may be transferred between pharmacies for the purpose of an
			 initial or refill dispensing provided that:
(a) The prescription is invalidated at the
			 sending pharmacy; and
(b) The
			 receiving pharmacy obtains all the information constituting the prescription
			 and its relevant refill history in a manner that ensures accuracy and
			 accountability.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0350 - Dispensing: Containers

Current through Register Vol. 63, No. 7, July 1, 2024
Each pharmacy must dispense a drug in a new container that
				complies with the current provisions of the Poison Prevention Packaging Act in
				16 CFR 1700 (01/01/2023), 16 CFR 1701 (01/01/2023), and 16 CFR 1702
				(01/01/2023).
Publications: Publications referenced are available for
				  review at the agency.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0355 - Dispensing: Customized Patient Medication Packages

Current through Register Vol. 63, No. 7, July 1, 2024
In lieu of dispensing two or more prescribed drug products in
				separate containers, an Oregon licensed Pharmacist may, with the consent of the
				patient, the patient's caregiver, or a prescriber, provide a customized patient
				medication package (patient med pak). A patient med pak is a package prepared
				by a Certified Oregon Pharmacy Technician or Pharmacy Technician and verified
				by a Pharmacist for a specific patient comprising a series of containers and
				containing two or more prescribed solid oral dosage forms. The patient med pak
				is so designed for each container is so labeled as to indicate the day and
				time, or period of time, that the contents within each container are to be
				taken:
(1) Label:
(a) The patient med pak must bear a label
			 stating:
(A) The name of the
			 patient;
(B) A serial number for
			 each patient med pak itself and a separate identifying serial number for each
			 of the prescription orders for each of the drug products contained
			 therein;
(C) The name, strength,
			 physical description or identification, and total quantity of each drug product
			 contained therein;
(D) The
			 directions for use and cautionary statements, if any, contained in the
			 prescription order for each drug product therein;
(E) Any storage instructions or cautionary
			 statements required by the official compendia;
(F) The name of the prescriber of each drug
			 product;
(G) The date of
			 preparation of the patient med pak and the beyond-use date assigned to the
			 patient med pak (such beyond-use date must be no later than 60 days from the
			 date of preparation);
(H) The name,
			 address, and telephone number of the dispenser and the dispenser's registration
			 number where necessary; and
(I) Any
			 other information, statements, or warnings required for any of the drug
			 products contained therein.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0360 - Dispensing: Interpretation

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 Except as provided in subsection (2) of this section, a Pharmacist or Intern
			 from the RDSP Affiliated Pharmacy must work with a health care interpreter from
			 the health care interpreter registry administered by the Oregon Health
			 Authority under ORS 413.558 when communicating with
			 a patient who prefers to communicate in a language other than English or who
			 communicates in signed language, unless the Pharmacist is proficient in the
			 preferred language of the person with limited English proficiency. The
			 Pharmacist or drug outlet may not charge for these services.
(2) A Pharmacist or Intern who is otherwise
			 required to work with a health care interpreter from the health care
			 interpreter registry may work with a health care interpreter who is not listed
			 on the health care interpreter registry only if the Pharmacist or Intern:
(a) Verifies that the Pharmacist or Intern
			 has made a good faith effort needed to obtain a health care interpreter from
			 the health care interpreter registry in accordance with rules adopted by the
			 authority under ORS 413.558 and has found that none
			 are available to provide interpretation; or
(b) Has offered the patient the services of a
			 health care interpreter from the health care interpreter registry and the
			 patient declined the offer and chose a different interpreter.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0400 - Labeling: General Requirements

Current through Register Vol. 63, No. 7, July 1, 2024
Prescriptions must be labeled with the following
				information:
(1) Name, address and
			 telephone number of the RDSP;
(2)
			 Date;
(3) Identifying
			 number;
(4) Name of
			 patient;
(5) Name of drug,
			 strength, and quantity dispensed; when a generic name is used, the label must
			 also contain the identifier of the manufacturer or distributor;
(6) Directions for use by the
			 patient;
(7) Name of
			 practitioner;
(8) Required
			 precautionary information regarding controlled substances;
(9) Such other and further accessory
			 cautionary information as required for patient safety;
(10) An expiration date after which the
			 patient should not use the drug or medicine. Expiration dates on prescriptions
			 must be the same as that on the original container unless, in the Oregon
			 licensed Pharmacist's professional judgment, a shorter expiration date is
			 warranted. Any drug bearing an expiration date must not be dispensed beyond the
			 said expiration date of the drug;
(11) Any dispensed prescription medication,
			 other than those in unit dose or unit of use packaging, must be labeled with
			 its physical description, including any identification code that may appear on
			 tablets and capsules; and
(12)
			 Address and telephone number of the RDSP Affiliated Pharmacy.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.505 & ORS
				  689.515
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0405 - Labeling: Prescription Reader Accessibility

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A pharmacy must notify each person to
			 whom a prescription drug is dispensed that a prescription reader is available
			 to the person upon request; a prescription reader is a device designed to
			 audibly convey labeling information.
(2) If a person informs the pharmacy that the
			 person identifies as a person who is blind, the pharmacy must provide to the
			 person a prescription reader that is available to the person for at least the
			 duration of the prescription, must confirm it is appropriate to address the
			 person's visual impairment, and must ensure that prescription labels are
			 compatible with the prescription reader. This requirement does not apply to an
			 institutional drug outlet, dispensing a drug intended for administration by a
			 healthcare provider.
(3) The
			 pharmacy must ensure an Oregon licensed Pharmacist verifies and documents that
			 the correct electronic label was placed on each prescription container and that
			 the audio information produced by the prescription reader is accurate prior to
			 dispensing the prescription.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.561
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0410 - Labeling: Limited English Proficiency and Accessibility

Current through Register Vol. 63, No. 7, July 1, 2024
1) Upon request of a prescriber, patient or a
			 patient's agent, each drug dispensed by a pharmacy for a patient's
			 self-administration must bear a label in both English and the language
			 requested for an individual with limited English proficiency, defined as a
			 person who is not fluent in the English language. This does not apply to a drug
			 outlet dispensing a drug intended for administration by a healthcare worker.
(2) When dispensing a drug under
			 (1), a pharmacy must provide labels and informational inserts in both English
			 and one of the following languages:
(a)
			 Spanish;
(b) Russian;
(c) Somali;
(d) Arabic;
(e) Chinese (simplified);
(f) Vietnamese;
(g) Farsi;
(h) Korean;
(i) Romanian;
(j) Swahili;
(k) Burmese;
(l) Nepali;
(m) Amharic; and
(n) Pashtu.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0450 - Drugs and Devices: Disposal

Current through Register Vol. 63, No. 7, July 1, 2024
Drugs and devices that are outdated, damaged, deteriorated,
				misbranded, or adulterated must be quarantined and physically separated from
				other drugs until they are destroyed or returned to their supplier.
Statutory/Other Authority: ORS
				  475.035, ORS
				  689.205, ORS
				  689.305 & ORS
				  689.315
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0455 - Drugs and Devices: Return

Current through Register Vol. 63, No. 7, July 1, 2024
A Certified Oregon Pharmacy Technician or Pharmacy Technician
				may accept the return of a drug or device as defined by ORS
				689.005 once the drug or device
				have been dispensed from the pharmacy if they were dispensed in error, were
				defective, adulterated, misbranded, dispensed beyond their expiration date, or
				are subject of a drug or device recall only if:
(1) An Oregon licensed Pharmacist has
			 approved the return;
(2) The drugs
			 or devices are accepted for destruction or disposal; and
(3) An Oregon licensed Pharmacist verifies
			 the destruction or disposal.
Statutory/Other Authority: ORS
				  689.205 & 2022 HB
				  4034
Statutes/Other Implemented: ORS
				  689.305 & 2022 HB
				  4034
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0460 - Drugs and Devices: Take-back Program

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A RDSP that
			 operates a drug take-back collection program or that participates in a drug
			 take-back program under ORS
			 459A.200 to ORS
			 459A.266 as an authorized
			 collector must be registered with the DEA as an authorized collector to collect
			 controlled and non-controlled drugs for destruction.
(2) A RDSP that operates as a Drug
			 Enforcement Agency (DEA) authorized collector must notify the board within 30
			 days of initiating or terminating the program and must establish and enforce
			 policies and procedures, including but not limited to:
(a) Provision of a secure location of the
			 collection receptacle inside the retail drug outlet, which is accessible to the
			 public, within view of the pharmacy counter and must not be located behind the
			 pharmacy counter; and
(b) Provision
			 of adequate security measures, including proper installation and maintenance of
			 the collection receptacle, tracking of liners, documentation, and key
			 accountability; and
(c) Personnel
			 training and accountability.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0500 - Policies and Procedures

Current through Register Vol. 63, No. 7, July 1, 2024
(1) The
			 Oregon licensed Pharmacist-in-charge of the RDSP Affiliated Pharmacy and the
			 RDSP Affiliated Pharmacy drug outlet is accountable for establishing,
			 maintaining, and enforcing written policies and procedures for the RDSP. The
			 written policies and procedures must be maintained at the RDSP Affiliated
			 Pharmacy and the RDSP and must be available to the board upon
			 request.
(2) The written policies
			 and procedures must include at a minimum the responsibilities of the RDSP
			 Affiliated Pharmacy and each RDSP including;
(a) Security;
(b) Operation, testing and maintenance of the
			 telepharmacy system;
(c)
			 Sanitation;
(d) Storage of
			 drugs;
(e) Dispensing;
(f) Oregon licensed Pharmacist supervision,
			 direction and control of pharmacy technicians;
(g) Documenting the identity, function,
			 location, date and time of the licensees engaging in telepharmacy;
(h) Drug and/or device procurement;
(i) Receiving of drugs and/or
			 devices;
(j) Delivery of drugs
			 and/or devices;
(k) Utilization of
			 Oregon licensed Pharmacist (i.e. DUR, Counseling);
(l) Recordkeeping;
(m) Patient confidentiality;
(n) On-site inspection by an Oregon licensed
			 Pharmacist;
(o) Continuous quality
			 improvement;
(p) Plan for
			 discontinuing and recovering services if telepharmacy system disruption
			 occurs;
(q) Training: initial and
			 ongoing; and
(r) Interpretation,
			 translation and prescription reader services.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0550 - Records: General Requirements

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 The recordkeeping requirements OAR 855-139 are in addition to the requirements
			 of other recordkeeping rules of the board. Unless otherwise specified, all
			 records and documentation required by these rules, must be retained for three
			 years and made available to the board for inspection upon request. Records must
			 be stored onsite for at least one year and may be stored, after one year, in a
			 secured off-site location if retrievable within three business days. Records
			 and documentation may be written, electronic or a combination of the
			 two.
(2) The RDSP must maintain all
			 required records unless these records are maintained in the RDSP Affiliated
			 Pharmacy.
(3) Records retained by
			 the Drug Outlet must include, but are not limited to:
(a) Patient profiles and records;
(b) Date, time and identification of each
			 individual and activity or function performed;
(c) If filling prescriptions, date, time and
			 identification of the licensee and the specific activity or function of the
			 person performing each step in the dispensing process;
(d) Controlled substance inventory and
			 reconciliation;
(e) Oregon licensed
			 Pharmacist physical inspection of RDSP;
(f) Audiovisual communication system testing
			 and individual training on use of the audiovisual communication
			 system;
(g) Still image capture and
			 store and forward images must be retained according to (1);
(h) Data, telephone audio and surveillance
			 system data must be retained for 6 months; and
(i) Any errors or irregularities identified
			 by the quality improvement program.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0555 - Records: Patient

Current through Register Vol. 63, No. 7, July 1, 2024
A patient record system must be maintained by pharmacies for
				all patients for whom a prescription drug is dispensed. The patient record
				system must provide information necessary for the dispensing Oregon licensed
				Pharmacist to identify previously dispensed drugs at the time a prescription is
				presented for dispensing. The pharmacist must make a reasonable effort to
				obtain, record, and maintain the following information:
(1) Full name of the patient for whom the
			 drug is intended;
(2) Address and
			 telephone number of the patient;
(3) Patient's age or date of birth;
(4) Patient's gender;
(5) Chronic medical conditions;
(6) A list of all prescription drug orders
			 obtained by the patient at the pharmacy maintaining the patient record showing
			 the name of the drug or device, prescription number, name and strength of the
			 drug, the quantity and date received, and the name of the prescriber;
(7) Known allergies, drug reactions, and drug
			 idiosyncrasies; and
(8) If deemed
			 relevant in the Oregon licensed Pharmacist's professional judgment:
(a) Oregon licensed Pharmacist comments
			 relevant to the individual's drug therapy, including any other information
			 peculiar to the specific patient or drug; and
(b) Additional information such as chronic
			 conditions or disease states of the patient, the patient's current weight, and
			 the identity of any other drugs, including over-the-counter drugs, or devices
			 currently being used by the patient which may relate to prospective drug
			 review.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0560 - Patients Access to Pharmacy Records

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Licensees and registrants of the board
			 must make protected health information in the pharmacy record available to the
			 patient or the patient's representative upon their request, to inspect and
			 obtain a copy of protected health information about the individual, except as
			 provided by law and this rule. The patient may request all or part of the
			 record. A summary may substitute for the actual record only if the patient
			 agrees to the substitution. Board licensees and registrants are encouraged to
			 use the written authorization form provided by ORS
			 192.566.
(2) For the purpose of this rule, "health
			 information in the pharmacy record" means any oral, written or electronic
			 information in any form or medium that is created or received and relates to:
(a) The past, present, or future physical or
			 mental health of the patient.
(b)
			 The provision of healthcare to the patient.
(c) The past, present, or future payment for
			 the provision of healthcare to the patient.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0600 - Prohibited Practices: General

Current through Register Vol. 63, No. 7, July 1, 2024
A Retail Drug Outlet RDSP must not:
(1) Allow a Certified Oregon Pharmacy
			 Technician or Pharmacy Technician to:
(a)
			 Refuse a request from a patient, patient's agent, or practitioner to interact
			 with a Pharmacist; and
(b)
			 Administer a vaccine.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0602 - Prohibited Practices: Disclosure of Patient Information

Current through Register Vol. 63, No. 7, July 1, 2024
A Retail Drug Outlet RDSP may not:
(1) Allow a licensee or registrant of the
			 board who obtains any patient information to disclose that information to a
			 third party without the consent of the patient except as provided in (2) of
			 this rule.
(2) A licensee may
			 disclose patient information:
(a) To the
			 board;
(b) To a practitioner,
			 Oregon licensed Pharmacist, Intern, Pharmacy Technician, or Certified Oregon
			 Pharmacy Technician, if disclosure is authorized by an Oregon-licensed
			 Pharmacist who reasonably believes that disclosure is necessary to protect the
			 patient's health or well-being; or
(c) To a third-party when disclosure is
			 authorized or required by law; or
(d) As permitted pursuant to federal and
			 state patient confidentiality laws; or
(e) To the patient or to persons as
			 authorized by the patient.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0650 - Grounds for Discipline

Current through Register Vol. 63, No. 7, July 1, 2024
The State Board of Pharmacy may impose one or more of the
				following penalties which includes: suspend, revoke, or restrict the license of
				an outlet or may impose a civil penalty upon the outlet upon the following
				grounds:
(1) Unprofessional conduct as
			 defined in OAR 855-006-0020;
(2) Advertising or soliciting that may
			 jeopardize the health, safety, or welfare of the patient including, but not be
			 limited to, advertising or soliciting that:
(a) Is false, fraudulent, deceptive, or
			 misleading; or
(b) Makes any claim
			 regarding a professional service or product or the cost or price thereof which
			 cannot be substantiated by the licensee.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0710 - Service: Epinephrine- Definitions

Current through Register Vol. 63, No. 7, July 1, 2024
The following words and terms, when used in OAR
				855-139-0710 through OAR
				855-139-0715 have the following
				meanings, unless the context clearly indicates otherwise.
(1) "Allergic reaction" means a medical
			 condition caused by exposure to an allergen, with physical symptoms that may be
			 life threatening, ranging from localized itching to severe anaphylactic shock
			 and death.
(2) "Authorization to
			 Obtain Epinephrine" means a certificate that contains the name, signature, and
			 license number of the supervising professional authorizing the dispensing of
			 epinephrine to the individual whose name appears on the certificate.
			 Additionally, the certificate contains a record of the number of epinephrine
			 orders filled to date.
(3)
			 "Statement of Completion" means a certificate that states the specific type of
			 emergency the trainee was trained to respond to, the trainee's name and
			 address, the name of the authorized trainer and the date that the training was
			 completed.
(4) "Trainee" means an
			 individual who has attended and successfully completed the formal training
			 pursuant to the protocols and criteria established by the Oregon Health
			 Authority, Public Health Division.
Statutory/Other Authority: ORS
				  689.205 & ORS
				  689.681
Statutes/Other Implemented: ORS
				  689.681 & ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0715 - Service: Epinephrine- General Requirements

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Certified Oregon Pharmacy Technician or
			 Pharmacy Technician may prepare for Oregon licensed Pharmacist verification an
			 order for epinephrine to be used by trainees to treat an anaphylactic reaction.
			 Trainees must be 18 years of age or older and must have responsibility for or
			 contact with at least one (1) other person as a result of the trainee's
			 occupation or volunteer status, such as, but not limited to, a camp counselor,
			 scout leader, forest ranger, school employee, tour guide or
			 chaperone.
(2) Individuals must
			 successfully complete a training program approved by the Oregon Health
			 Authority, Public Health Division. Upon successful completion, the trainee will
			 receive the following certificates:
(a)
			 Statement of Completion; and
(b)
			 Authorization to Obtain Epinephrine.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0720

Current through Register Vol. 63, No. 7, July 1, 2024
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.305, ORS
				  689.681 & ORS
				  689.682
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0725 - Service: Expedited Partner Therapy (EPT)- Purpose

Current through Register Vol. 63, No. 7, July 1, 2024
(1) There is substantial evidence that rates
			 of re-infection with certain sexually transmitted diseases can be reduced by
			 treating all sexual partners for the disease, even when the treating clinician
			 has not examined those partners. This practice is known as Expedited Partner
			 Therapy.
(2) Because of the
			 important public health implications, the 2009 Oregon Legislature passed HB
			 3022 authorizing this practice. This law permits health professional regulatory
			 boards to adopt rules permitting practitioners to practice Expedited Partner
			 Therapy.
(3) The law specifies that
			 a prescription issued in the practice of Expedited Partner Therapy is valid,
			 even if the name of the patient the prescription is intended for is not on the
			 prescription.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.505
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 139 - REMOTE DISPENSING SITE PHARMACY › Section 855-139-0730 - Service: Expedited Partner Therapy (EPT) - Procedures

Current through Register Vol. 63, No. 7, July 1, 2024
(1) "Expedited Partner Therapy (EPT)" means
			 the practice of prescribing or dispensing an antibiotic drug for the treatment
			 of a sexually transmitted disease to the partner of a patient without first
			 examining that partner.
(2)
			 Notwithstanding any other rules in this division that mandate requirements for
			 a valid prescription and for labeling, when a prescription is marked EPT or a
			 similar notation by the prescribing practitioner, this rule govern.
(3) An EPT prescription may only be dispensed
			 for a drug that has been determined by the Oregon Health Authority (OHA) to be
			 appropriately used for EPT.
(4)
			 Prescription;
(a) An EPT treatment protocol
			 must conform to the following:
(A) It must
			 include a prescription for each named or unnamed partner of the
			 patient;
(B) It must contain a
			 handwritten or electronic signature of the prescribing practitioner;
(C) The practitioner must identify the
			 prescription in the following manner:
(i)
			 Write "for EPT," or a similar notation, on the face of the
			 prescription;
(ii) For a verbal
			 order, the practitioner must identify the prescription as an "EPT
			 Prescription," or similar identification;
(iii) The practitioner must identify the
			 prescription for each partner either by including the name of the patient, such
			 as "John Doe - Partner 1" or by labeling the prescription as "EPT
			 Partner".
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 141 - PHARMACY PRESCRIPTION KIOSK › Section 855-141-0001 - Purpose and Scope

Current through Register Vol. 63, No. 7, July 1, 2024
The purpose of OAR 855-141 is to provide minimum requirements
				for the operation of a Pharmacy Prescription Kiosk (PPK) by a PPK Affiliated
				Pharmacy.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.155, ORS
				  689.527
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 141 - PHARMACY PRESCRIPTION KIOSK › Section 855-141-0005 - Definitions

Current through Register Vol. 63, No. 7, July 1, 2024
(1) "Pharmacy
			 Prescription Kiosk Affiliated Pharmacy" or "PPK Affiliated Pharmacy" means a
			 Retail Drug Outlet Pharmacy registered in Oregon that operates a Pharmacy
			 Prescription Kiosk.
(2) "Pharmacy
			 Prescription Kiosk" or "PPK" means an Oregon location registered as a Retail
			 Drug Outlet Pharmacy Prescription Kiosk using a mechanical system that stores
			 and dispenses patient-specific prescription and nonprescription drugs, devices,
			 and related supplies.
(3)
			 "Telepharmacy system" means a system of telecommunications technologies that
			 enables documenting and recording of the delivery of pharmacy services at a
			 remote location by an electronic method.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.155, ORS
				  689.527